With the publication pending and expected soon, it's time to think of questions you would like to see answered in the paper. A chance to critique, criticise and question, much in the way we did with Lenire (very well) and Frequency Therapeutics/Otonomy (not so well) over the last couple of years.
So what questions/information would you pay particular interest to? Remember this is a publication and not a speculative piece, so expecting information on non somatic cases or reactive tinnitus is not going to be included.
For me:
So what questions/information would you pay particular interest to? Remember this is a publication and not a speculative piece, so expecting information on non somatic cases or reactive tinnitus is not going to be included.
For me:
- How many were originally recruited and how many dropped out?
- What were the reasons for dropouts?
- How many side effects were they and what were they?
- I want to see results from both groups, so those that received the treatment first and those that received the sham first. I don't think the preliminary findings had this?
- The validity of the TinnTester as a recognised test.
- Were there variations in efficacy based on chronicity of tinnitus?
- Information on standard deviations, outliers for super responders and non responders.
- Was information on comorbidities, like depression and anxiety, taken into account/randomised as this can affect particularly the THI scores?
- Directions for future studies and/or research based on the findings?